FCGR2A and infection: Antibody-dependent enhancement (ADE) is the mechanism by which the heterologous antibodies (IgG), irrespective of the neutralizing capabilities, surround DENV during the secondary infection and present it to FcγR bearing cells to enhance DENV infection [8,36,37,38,39,40,41,42,43].